Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?

Find People
Find Everything
About This Site
Edit My Profile
Export RDF
Login to Profiles

Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?

O'Donnell PH, Stadler WM. Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II? Clin Cancer Res. 2012 May 15; 18(10):2809-16.

View in: PubMed

subject areas

Antineoplastic Agents
Clinical Trials, Phase II as Topic
Humans
Medical Oncology
Neoplasms
Pharmacogenetics
Randomized Controlled Trials as Topic

authors with profiles

Walter M. Stadler
Peter H. O'Donnell